Chemotherapy-free treatment approaches in lymphoma #2

MEET THE EXPERTS ALL PROGRAMMES DEVELOPED COLLABORATIONS CONTACT

Chemotherapy-free treatment approaches in lymphoma #2

Dr. Loretta Nastoupil shares an American Perspective on Chemotherapy-free treatment approach in lymphoma. E-learning also available Dr. Loretta Nastoupil shares an American Perspective on Chemotherapy-free treatment approach in lymphoma. E-learning also available

Assoc. Prof. Loretta Nastoupil

Watch the videos, download the slides and take the e-learning

Assoc. Prof. Loretta Nastoupil

Haematologist

MD Anderson Cancer Center

United States (US)

Biography Disclosures

Assoc. Prof. Loretta Nastoupil

Haematologist

MD Anderson Cancer Center

United States (US)

Loretta Nastoupil, MD, completed her undergraduate degree at Texas Tech Health Sciences Center, graduating summa cum laude in 2003. She obtained her medical degree from the University of Texas Southwestern Medical School at Dallas in 2007. Dr Nastoupil completed her internship and internal medicine residency at Washington University, Barnes-Jewish Hospital in St. Louis, Missouri. Following residency, she completed a hematology-medical oncology fellowship at Emory University, serving as chief fellow her last year. Dr Nastoupil joined the faculty at MD Anderson Cancer Center in 2013 as an assistant professor in the Department of Lymphoma/Myeloma. Dr Nastoupil is a clinical researcher with a focus on lymphoma epidemiology and outcomes. The goal of her research is to identify risk factors associated with lymphoma and eliminate disparities in outcomes to improve survival for all patients with lymphoma. She is actively involved in early phase drug development as well as immune therapy studies in indolent lymphoma. She is also actively exploring predictive biomarkers with modern therapy in lymphoma.

Assoc. Prof. Loretta Nastoupil has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Bayer, BMS, Genentech, Epizyme,Gilead/Kite, Novartis, TG Theraputics and Pfizer.

time E-learning | open 5 min |accreditation: EACCME | Feb 2020

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

download resources

DOWNLOAD SLIDES PPTX

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

This course has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) and ECMEC® is available. Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.

LYMPHOMA & MYELOMA CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer and from Karyopharm Therapeutics.

Other programmes of interest

Dr Matthew J. Matasar

4 min

Update From ASH 2022

Dec 2022

Asst. Prof. Hans Lee

2 min

Update from ASCO 2022 - Myeloma

May 2022

Dr. Alexander Lesokhin and Dr. Maria Victoria Mateos

Assoc. Prof. María Victoria Mateos

Dr Alexander M Lesokhin

Podcast

20 min

Podcast: Choosing the Best Treatment Regimen in Patients with Hig...

Mar 2022

Dr Matthew J. Matasar

5 min

Lymphoma Update from ASH 2021

Dec 2021

Translating the biology of diffuse large b cell lymphoma into treatment The Oncologist

Dr Matthew J. Matasar

Dr Massimo Magagnoli

Prof. Alexey V Danilov

5 min

DLBCL Review Paper Published in The Oncologist

Jan 2022

Dr Claudio Cerchione

10 min

Update from the 2021 Autumn Congresses in Multiple Myeloma

Nov 2021

Assoc. Prof. Karthik Ramasamy

Assoc. Prof. Joshua Richter

Podcast

25 min

Podcast: Choosing the Best Treatment Regimen in RRMM (Episode 2 o...

Oct 2021

Dr. Joshua Richter and Dr. Karthik Ramasamy

Assoc. Prof. Karthik Ramasamy

Assoc. Prof. Joshua Richter

Podcast

20 min

Podcast: Choosing the Best Treatment Regimen in NDMM (Episode 1 o...

Oct 2021

Assoc. Prof. Tycel Phillips

5 min

Highlights in Lymphoma

Jul 2021

Update from ASCO and EHA 2021 on Multiple Myeloma - LYMPHOMA & MYELOMA CONNECT

Asst. Prof. Hans Lee

5 min

Update from ASCO and EHA 2021 on Multiple Myeloma

Jun 2021

Assoc. Prof. María Victoria Mateos

5 min

Highlights in Multiple Myeloma

Jun 2021

Prof. Stefano Luminari

5 min

Update from ASH 2018 #2

2018

Other programmes developed by Assoc. Prof. Loretta Nastoupil

Assoc. Prof. Loretta Nastoupil

Haematologist

MD Anderson Cancer Center

United States (US)

Assoc. Prof. Loretta Nastoupil

5 min

Update from ASH 2018 #1

2018

LYMPHOMA CONNECT review paper published in The Oncologist - LYMPHOMA & MYELOMA CONNECT

Prof. Alexey V Danilov

Assoc. Prof. Loretta Nastoupil

Dr Matthew J. Matasar

And others...

0 min

Follicular Lymphoma Review Paper Published in The Oncologist

2019

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.